nach oben

Lasers in Medical Science

Erschienen in:

01.02.2013 | Review Article

Laser treatment for retinopathy of prematurity

verfasst von: Samuel K. Houston, Charles C. Wykoff, Audina M. Berrocal, Ditte J. Hess, Timothy G. Murray

Erschienen in: Lasers in Medical Science | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

Retinal development involves a complex coordination of events that may be affected by premature delivery, leading to retinopathy of prematurity (ROP), a potential blinding childhood disease. The avascular retina drives further disease progression, with laser ablation reducing unfavorable anatomic outcomes as well as maintaining visual acuity. Trials have stressed the importance of early identification and treatment of threshold and high-risk prethreshold disease to improve outcomes. Retinal ablation with laser photocoagulation should involve entire treatment of avascular retina with a confluent laser spot density, avoiding skip lesions. The current review highlights the use of laser photocoagulation in the treatment of ROP.

Terry TL (1944) Retrolental fibroplasia in the premature infant: v. further studies on fibroplastic overgrowth of the persistent tunica vasculosa lentis. Trans Am Ophthalmol Soc 42:383–396PubMed

Goldberg MF (1997) Persistent fetal vasculature (PFV): an integrated interpretation of signs and symptoms associated with persistent hyperplastic primary vitreous (PHPV). LIV Edward Jackson Memorial Lecture. Am J Ophthalmol 124(5):587–626PubMed

Michaelson IC (1948) Vascular morphogenesis in the retina of the cat. J Anat 82(3):167–174, 4

Ashton N, Cook C (1954) Direct observation of the effect of oxygen on developing vessels: preliminary report. Br J Ophthalmol 38(7):433–440PubMedCrossRef

Xu Q et al (2004) Vascular development in the retina and inner ear: control by Norrin and Frizzled-4, a high-affinity ligand-receptor pair. Cell 116(6):883–895PubMedCrossRef

Hughes S, Yang H, Chan-Ling T (2000) Vascularization of the human fetal retina: roles of vasculogenesis and angiogenesis. Invest Ophthalmol Vis Sci 41(5):1217–1228PubMed

Chan-Ling T et al (2004) Desmin ensheathment ratio as an indicator of vessel stability: evidence in normal development and in retinopathy of prematurity. Am J Pathol 165(4):1301–1313PubMedCrossRef

Chan-Ling T, Gock B, Stone J (1995) The effect of oxygen on vasoformative cell division. evidence that ‘physiological hypoxia’ is the stimulus for normal retinal vasculogenesis. Invest Ophthalmol Vis Sci 36(7):1201–1214PubMed

Shweiki D et al (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359(6398):843–845PubMedCrossRef

10.

Smith LE (2008) Through the eyes of a child: understanding retinopathy through ROP (The Friedenwald lecture). Invest Ophthalmol Vis Sci 49(12):5177–5182PubMedCrossRef

11.

Hellstrom A et al (2001) Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity. Proc Natl Acad Sci USA 98(10):5804–5808PubMedCrossRef

12.

Heidary G, Vanderveen D, Smith LE (2009) Retinopathy of prematurity: current concepts in molecular pathogenesis. Semin Ophthalmol 24(2):77–81PubMedCrossRef

13.

Terry TL (1942) Fibroblastic overgrowth of persistent tunica vasculosa lentis in infants born prematurely: ii. report of cases-clinical aspects. Trans Am Ophthalmol Soc 40:262–284PubMed

14.

Tasman W et al (2006) Retinopathy of prematurity: the life of a lifetime disease. Am J Ophthalmol 141(1):167–174PubMedCrossRef

15.

Ashton N, Ward B, Serpell G (1953) Role of oxygen in the genesis of retrolental fibroplasia; a preliminary report. Br J Ophthalmol 37(9):513–520PubMedCrossRef

16.

Ashton N (1954) Pathological basis of retrolental fibroplasia. Br J Ophthalmol 38(7):385–396PubMedCrossRef

17.

Palmer EA et al (2005) 15-year outcomes following threshold retinopathy of prematurity: final results from the multicenter trial of cryotherapy for retinopathy of prematurity. Arch Ophthalmol 123(3):311–318PubMedCrossRef

18.

Cryotherapy for Retinopathy of Prematurity Cooperative Group (1988) Multicenter trial of cryotherapy for retinopathy of prematurity. preliminary results. Arch Ophthalmol 106(4):471–479CrossRef

19.

Good WV (2004) Final results of the early treatment for retinopathy of prematurity (ETROP) randomized trial. Trans Am Ophthalmol Soc 102:233–248, Discussion 248–50PubMed

20.

(2000) Supplemental Therapeutic Oxygen for Pre threshold Retinopathy Of Prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes. Pediatrics 105(2):295–310

21.

Askie LM, Henderson-Smart DJ, Ko H (2009) Restricted versus liberal oxygen exposure for preventing morbidity and mortality in preterm or low birth weight infants. Cochrane Database Syst Rev (1):CD001077

22.

Section on Ophthalmology American Academy of Pediatrics; American Academy of Ophthalmology; American Association for Pediatric Ophthalmology and Strabismus (2006) Screening examination of premature infants for retinopathy of prematurity. Pediatrics 117(2):572–576

23.

Clark D, Mandal K (2008) Treatment of retinopathy of prematurity. Early Hum Dev 84(2):95–99PubMedCrossRef

24.

International Committee for the Classification of Retinopathy of Prematurity (2005) The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol 123(7):991–999

25.

Chiang MF et al (2007) Interexpert agreement of plus disease diagnosis in retinopathy of prematurity. Arch Ophthalmol 125(7):875–880PubMedCrossRef

26.

Lorenz B et al (2009) Wide-field digital imaging based telemedicine for screening for acute retinopathy of prematurity (ROP). Six-year results of a multicentre field study. Graefes Arch Clin Exp Ophthalmol 247(9):1251–1262PubMedCrossRef

27.

Ells AL et al (2003) Telemedicine approach to screening for severe retinopathy of prematurity: a pilot study. Ophthalmology 110(11):2113–2117PubMedCrossRef

28.

Schwartz SD et al (2000) Telemedical evaluation and management of retinopathy of prematurity using a fiberoptic digital fundus camera. Ophthalmology 107(1):25–28PubMedCrossRef

29.

Wallace DK, Freedman SF, Zhao Z (2009) A pilot study using ROPtool to measure retinal vascular dilation. Retina 29(8):1182–1187PubMedCrossRef

30.

Murakami Y et al (2010) Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP): 24-month experience with telemedicine screening. Acta Ophthalmol 88(3):317–322PubMed

31.

Seiberth V et al (1995) Diode laser photocoagulation for stage 3+ retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol 233(8):489–493PubMedCrossRef

32.

McNamara JA et al (1992) Diode laser photocoagulation for retinopathy of prematurity. preliminary results. Arch Ophthalmol 110(12):1714–1716PubMedCrossRef

33.

Banach MJ, Ferrone PJ, Trese MT (2000) A comparison of dense versus less dense diode laser photocoagulation patterns for threshold retinopathy of prematurity. Ophthalmology 107(2):324–327, discussion 328PubMedCrossRef

34.

Tsitsis T et al (1997) Diode laser photocoagulation for retinopathy of prematurity. Trans Am Ophthalmol Soc 95:231–236, discussion 237–45PubMed

35.

Shalev B, Farr AK, Repka MX (2001) Randomized comparison of diode laser photocoagulation versus cryotherapy for threshold retinopathy of prematurity: seven-year outcome. Am J Ophthalmol 132(1):76–80PubMedCrossRef

36.

Cryotherapy for Retinopathy of Prematurity Cooperative Group (2002) Multicenter trial of cryotherapy for retinopathy of prematurity: natural history ROP: ocular outcome at 5(1/2) years in premature infants with birth weights less than 1251 g. Arch Ophthalmol 120(5):595–599

37.

Connolly BP et al (2002) A comparison of laser photocoagulation with cryotherapy for threshold retinopathy of prematurity at 10 years: part 2. Refractive outcome. Ophthalmology 109(5):936–941PubMedCrossRef

38.

Ng EY et al (2002) A comparison of laser photocoagulation with cryotherapy for threshold retinopathy of prematurity at 10 years: part 1. Visual function and structural outcome. Ophthalmology 109(5):928–934, discussion 935PubMedCrossRef

39.

Early Treatment For Retinopathy Of Prematurity Cooperative (2003) Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol 121(12):1684–1694CrossRef

40.

Good WV et al (2010) Final visual acuity results in the early treatment for retinopathy of prematurity study. Arch Ophthalmol 128(6):663–671PubMedCrossRef

41.

McNamara JA (1993) Laser treatment for retinopathy of prematurity. Curr Opin Ophthalmol 4(3):76–80PubMedCrossRef

42.

Banach MJ, Berinstein DM (2001) Laser therapy for retinopathy of prematurity. Curr Opin Ophthalmol 12(3):164–170PubMedCrossRef

43.

Rezai KA et al (2005) Near confluent laser photocoagulation for the treatment of threshold retinopathy of prematurity. Arch Ophthalmol 123(5):621–626PubMedCrossRef

44.

Prenner JL, Capone A Jr, Trese MT (2004) Visual outcomes after lens-sparing vitrectomy for stage 4A retinopathy of prematurity. Ophthalmology 111(12):2271–2273PubMedCrossRef

45.

Kaiser RS, Trese MT (2001) Iris atrophy, cataracts, and hypotony following peripheral ablation for threshold retinopathy of prematurity. Arch Ophthalmol 119(4):615–617PubMed

46.

Lambert SR et al (2000) Cataract and phthisis bulbi after laser photoablation for threshold retinopathy of prematurity. Am J Ophthalmol 129(5):585–591PubMedCrossRef

47.

Simons BD et al (1998) Bilateral hyphemas and cataracts after diode laser retinal photoablation for retinopathy of prematurity. J Pediatr Ophthalmol Strabismus 35(3):185–187PubMed

48.

Gaitan JR et al (2008) Anterior segment ischemia following laser therapy for threshold retinopathy of prematurity. Retina 28(3):55–57CrossRef

49.

Christiansen SP, Bradford JD (1995) Cataract in infants treated with argon laser photocoagulation for threshold retinopathy of prematurity. Am J Ophthalmol 119(2):175–180PubMed

50.

Drack AV et al (1992) Transient punctate lenticular opacities as a complication of argon laser photoablation in an infant with retinopathy of prematurity. Am J Ophthalmol 113(5):583–584PubMed

51.

Kent D et al (2000) The influence of retinopathy of prematurity on ocular growth. Eye (Lond) 14(1):23–29CrossRef

52.

Lalwani GA et al (2008) Off-label use of intravitreal bevacizumab (Avastin) for salvage treatment in progressive threshold retinopathy of prematurity. Retina 28(3):13–18CrossRef

53.

Mintz-Hittner HA, Kuffel RR Jr (2008) Intravitreal injection of bevacizumab (Avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II. Retina 28(6):831–838PubMedCrossRef

54.

Kusaka S et al (2008) Efficacy of intravitreal injection of bevacizumab for severe retinopathy of prematurity: a pilot study. Br J Ophthalmol 92(11):1450–1455PubMedCrossRef

55.

Quiroz-Mercado H et al (2008) Antiangiogenic therapy with intravitreal bevacizumab for retinopathy of prematurity. Retina 28(3):19–25CrossRef

56.

Wu WC et al (2011) Effects and complications of bevacizumab use in patients with retinopathy of prematurity: a multicenter study in Taiwan. Ophthalmology 118(1):176–183PubMedCrossRef

57.

Mintz-Hittner HA, Kennedy KA, Chuang AZ (2011) Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med 364(7):603–615PubMedCrossRef

58.

Shah N et al (2010) The effect of recombinant human erythropoietin on the development of retinopathy of prematurity. Am J Perinatol 27(1):67–71

59.

Connor KM et al (2007) Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nat Med 13(7):868–873PubMedCrossRef

60.

Mantagos IS, Vanderveen DK, Smith LE (2009) Emerging treatments for retinopathy of prematurity. Semin Ophthalmol 24(2):82–86PubMedCrossRef

Titel: Laser treatment for retinopathy of prematurity
verfasst von: Samuel K. Houston
Charles C. Wykoff
Audina M. Berrocal
Ditte J. Hess
Timothy G. Murray
Publikationsdatum: 01.02.2013
Verlag: Springer-Verlag
Erschienen in: Lasers in Medical Science / Ausgabe 2/2013
Print ISSN: 0268-8921
Elektronische ISSN: 1435-604X
DOI: https://doi.org/10.1007/s10103-011-1021-z

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2013

Oncological and functional outcome after transoral 532-nm pulsed potassium-titanyl-phosphate laser surgery for T1a glottic carcinoma

The effects of Photofrin-mediated photodynamic therapy on the modulation of EGFR in esophageal squamous cell carcinoma cells

Effects of LLLT in combination with bisphosphonate on bone healing in critical size defects: a histological and histometric study in rat calvaria

Diode laser (980 nm) enucleation of the prostate: a promising alternative to transurethral resection of the prostate

Time-dependent effects of low-level laser therapy on the morphology and oxidative response in the skin wound healing in rats

Controlled synthesis, characterization, and application of iron oxide nanoparticles for oral delivery of insulin